Revolution Medicines (RVMD) Revenue & Revenue Breakdown
Revolution Medicines Revenue Highlights
Main Segment (Y)
Collaboration Revenue Member
Revolution Medicines Revenue by Period
Revolution Medicines Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $11.58M | -67.27% |
| 2022-12-31 | $35.38M | 20.38% |
| 2021-12-31 | $29.39M | -31.62% |
| 2020-12-31 | $42.98M | -14.10% |
| 2019-12-31 | $50.04M | 148.16% |
| 2018-12-31 | $20.16M | 100.00% |
| 2017-12-31 | - | - |
Revolution Medicines generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Revolution Medicines Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $261.59M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $742.00K | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $3.82M | -45.48% |
| 2023-03-31 | $7.01M | -54.25% |
| 2022-12-31 | $15.33M | 356.79% |
| 2022-09-30 | $3.36M | -63.19% |
| 2022-06-30 | $9.12M | 20.30% |
| 2022-03-31 | $7.58M | -19.89% |
| 2021-12-31 | $9.46M | 759.22% |
| 2021-09-30 | $1.10M | -87.34% |
| 2021-06-30 | $8.70M | -14.14% |
| 2021-03-31 | $10.13M | 15.77% |
| 2020-12-31 | $8.75M | -30.88% |
| 2020-09-30 | $12.66M | 26.29% |
| 2020-06-30 | $10.03M | -13.17% |
| 2020-03-31 | $11.55M | -4.48% |
| 2019-12-31 | $12.09M | -3.34% |
| 2019-09-30 | $12.51M | 1.83% |
| 2019-06-30 | $12.28M | -6.72% |
| 2019-03-31 | $13.17M | 27.24% |
| 2018-12-31 | $10.35M | - |
Revolution Medicines generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Revolution Medicines Revenue Breakdown
Revolution Medicines Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|
| Collaboration Revenue Member | $35.38M | $29.39M | - |
| Collaboration Revenue Related Party | - | - | $42.98M |
Revolution Medicines's latest annual revenue breakdown by segment (product or service), as of Dec 22: Collaboration Revenue Member (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue Member | $7.01M | $15.33M | $3.36M | $9.12M | $9.46M | - | - | - | - | - | - | - | - |
| Collaboration Revenue | - | - | - | - | $7.58M | $1.10M | $8.70M | $10.13M | - | - | - | - | - |
| Collaboration Revenue Related Party | - | - | - | - | - | - | - | - | - | $8.75M | $12.66M | $10.03M | $11.55M |
Revolution Medicines's latest quarterly revenue breakdown by segment (product or service), as of Mar 23: Collaboration Revenue Member (100.00%).
Revolution Medicines Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue Member | $7.01M | $15.33M | $3.36M | $9.12M | $9.46M | - | - | - | - | - | - | - | - |
| Collaboration Revenue | - | - | - | - | $7.58M | $1.10M | $8.70M | $10.13M | - | - | - | - | - |
| Collaboration Revenue Related Party | - | - | - | - | - | - | - | - | - | $8.75M | $12.66M | $10.03M | $11.55M |
Revolution Medicines's latest quarterly revenue breakdown by geography, as of Mar 23: Collaboration Revenue Member (100.00%).
Revolution Medicines Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals | $4.07B | $1.05B |
| MRNA | Moderna | $3.24B | $143.00M |
| BMRN | BioMarin Pharmaceutical | $2.85B | $825.41M |
| TECH | Bio-Techne | $1.16B | $297.03M |
| CAI | Caris Life Sciences | $294.01M | $100.83M |
| BBIO | BridgeBio Pharma | $221.90M | $71.50M |
| MDGL | Madrigal Pharmaceuticals | $180.13M | $212.80M |
| VRNA | Verona Pharma | $42.28M | $76.26M |
| MRUS | Merus | $36.13M | $8.83M |
| CYTK | Cytokinetics | $18.47M | $1.58M |
| RVMD | Revolution Medicines | - | - |